MKI67 and neoplasm: Ki67 staining to examine tumor cell proliferation in MKN-45 subcutaneous xenografts demonstrated that monotherapy with nintedanib and all cytotoxic agents reduced tumor cell proliferation, while combinations of nintedanib with cytotoxic agents were more effective than single agents.